Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-128492
Filing Date
2024-12-13
Accepted
2024-12-13 17:00:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2431063d1_424b5.htm 424B5 7953
2 GRAPHIC tm2431063d1_424b5img001.jpg GRAPHIC 6486
  Complete submission text file 0001104659-24-128492.txt   18071
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269429 | Film No.: 241549203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)